Could your own poop prevent a deadly infection after transplant?
NCT ID NCT02269150
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving patients their own preserved stool (collected before a stem cell transplant) can prevent Clostridium difficile infection afterward. About 59 adults receiving an allogeneic stem cell transplant are randomly assigned to get the stool transplant or standard care. The goal is to see if this approach lowers the chance of developing C. diff, a serious gut infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous fecal microbiota transplantation (stool transplant made from the patient's own stool)
- What this could lead to
- If it works, this could offer a way to prevent serious C. difficile infections in people who have had a stem cell transplant.
- What could go wrong
- This is a small, early-phase trial with only 59 participants, so results may not apply to everyone. The procedure is experimental and may not reduce infection risk as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States